Report Assesses Patient Portal Options
Vendor research firm KLAS Enterprises LLC has released a report that assesses patient portal technologies that provider organizations can use to comply with the meaningful use stage 2 requirements.
The Orem, Utah-based company’s report, “Patient Portals 2013: On Track for Meaningful Use?” is based on interviews with more than 200 provider organizations. It found that while healthcare organizations previously had relied on multiple add-on systems to support patient access to their clinical data, many now believe that their EHR vendors’ systems are better equipped than third-party software for such applications.
While this strategy can offer a more holistic approach to workflow and compliance, providers shouldn’t discount patient portal applications from best-of-breed vendors, according to the report.
“The HITECH Act that launched MU Stage 2 is clearly aiding the EMR vendors in this segment,” says report author and research director Mark Alphin. “However, there are advantages to looking outside your EMR. Many providers are still trying to determine which portal solution will be best to meet their needs, now and in the future as they continue to engage their patients on a deeper level.”
KLAS has included performance data on patient portal applications from various vendors in the report. While some providers reported that they were confident in their patient portal’s ability to satisfy the meaningful use stage 2 requirements, others are still waiting for addition functionality from their systems to help them comply. The report also offers provider feedback on both the current stages of the products and areas for future growth.
Providers and vendors can purchase the report at klasresearch.com/reports. Providers can receive a significant discount or a complimentary summary report in exchange for a survey about one of their vendors.